Lu Li
Stock Analyst at Bank of America Securities
(2.36)
# 3,119
Out of 5,184 analysts
52
Total ratings
56.5%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Reiterated: Hold | $185 | $151.59 | +22.04% | 3 | Nov 16, 2026 | |
| SDGR Schrödinger | Reiterated: Buy | n/a | $26.34 | - | 1 | Nov 10, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $145.59 | - | 2 | Nov 6, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | n/a | $18.54 | - | 2 | Nov 5, 2026 | |
| MYGN Myriad Genetics | Reiterated: Sell | n/a | $5.54 | - | 9 | Nov 5, 2026 | |
| TEM Tempus AI | Reiterated: Hold | $75 → $90 | $59.61 | +50.98% | 2 | Nov 2, 2026 | |
| ILMN Illumina | Reiterated: Sell | $168 → $200 | $200.66 | -0.33% | 2 | Oct 29, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | n/a | $368.88 | - | 2 | Oct 29, 2026 | |
| NEO NeoGenomics | Reiterated: Hold | n/a | $15.09 | - | 3 | Oct 29, 2026 | |
| DGX Quest Diagnostics | Reiterated: Buy | $265 | $259.09 | +2.28% | 1 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $270 | $227.56 | +18.65% | 3 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $15.12 | +12.43% | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $190.36 | - | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $49.63 | +0.75% | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 | $175.34 | +2.66% | 1 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $17 → $12 | $8.92 | +34.53% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $52 | $25.04 | +107.67% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 → $375 | $456.48 | -17.85% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $22 | $24.78 | -11.22% | 3 | Mar 2, 2026 |
Revvity
Nov 16, 2026
Reiterated: Hold
Price Target: $185
Current: $151.59
Upside: +22.04%
Schrödinger
Nov 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.34
Upside: -
Guardant Health
Nov 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $145.59
Upside: -
Caris Life Sciences
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.54
Upside: -
Myriad Genetics
Nov 5, 2026
Reiterated: Sell
Price Target: n/a
Current: $5.54
Upside: -
Tempus AI
Nov 2, 2026
Reiterated: Hold
Price Target: $75 → $90
Current: $59.61
Upside: +50.98%
Illumina
Oct 29, 2026
Reiterated: Sell
Price Target: $168 → $200
Current: $200.66
Upside: -0.33%
Labcorp Holdings
Oct 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $368.88
Upside: -
NeoGenomics
Oct 29, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.09
Upside: -
Quest Diagnostics
Oct 22, 2026
Reiterated: Buy
Price Target: $265
Current: $259.09
Upside: +2.28%
Oct 21, 2026
Reiterated: Buy
Price Target: $255 → $270
Current: $227.56
Upside: +18.65%
Oct 9, 2026
Reiterated: Hold
Price Target: $17
Current: $15.12
Upside: +12.43%
Oct 9, 2026
Upgraded: Hold
Price Target: n/a
Current: $190.36
Upside: -
Oct 9, 2026
Reiterated: Buy
Price Target: $50
Current: $49.63
Upside: +0.75%
Sep 28, 2026
Reiterated: Buy
Price Target: $180
Current: $175.34
Upside: +2.66%
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $8.92
Upside: +34.53%
May 6, 2026
Reiterated: Buy
Price Target: $48 → $52
Current: $25.04
Upside: +107.67%
May 6, 2026
Reiterated: Hold
Price Target: $330 → $375
Current: $456.48
Upside: -17.85%
Mar 2, 2026
Reiterated: Buy
Price Target: $35 → $22
Current: $24.78
Upside: -11.22%